中药辅助治疗对2型糖尿病脑卒中患者生存的影响
本研究在台湾识别3079例2型糖尿病合并脑卒中患者,按年龄、性别和病程匹配618例为中药组与非中药组。中药组累积生存概率更高(P<0.001),校正合并症、收入和城市化水平后死亡风险比为0.37(95%CI 0.25-0.55)。常用方剂包括舒筋活血汤、血府逐瘀汤、独活寄生汤,常用单味药为丹参、牛膝、延胡索。
要点
- 中药作为辅助治疗可能改善2型糖尿病脑卒中患者的总生存。
- 校正混杂后中药组死亡风险显著低于非中药组(HR 0.37)。
- 常用方剂为舒筋活血汤、血府逐瘀汤、独活寄生汤。
核心结论
- 中药作为辅助治疗可能改善2型糖尿病脑卒中患者的总生存。
- 中药组校正后死亡风险比非中药组低(HR 0.37,95%CI 0.25-0.55)。
- 常用方剂和单味药清单可为未来大规模随机临床研究提供参考。
研究设计与样本
- 研究在台湾识别3079例2型糖尿病合并脑卒中患者(ICD-9-CM: 430-438)。
- 按年龄、性别和2型糖尿病至脑卒中病程匹配618例,分为中药组和非中药组。
- 采用卡方检验、条件多变量逻辑回归、Kaplan-Meier法和log-rank检验进行分析。
主要发现
- 中药组累积生存概率高于非中药组(P<0.001,log-rank检验)。
- 校正合并症、收入和城市化水平后,中药组死亡风险比为0.37(95%CI 0.25-0.55)。
- 中药组更多患者有慢性阻塞性肺疾病、溃疡病、高脂血症、吸烟史和较高收入。
- 常用方剂前三位为舒筋活血汤、血府逐瘀汤、独活寄生汤。
- 常用单味药前三位为丹参、牛膝、延胡索。
临床怎么用
- 对2型糖尿病合并脑卒中患者,可考虑在常规治疗基础上加用中药作为辅助治疗。
- 舒筋活血汤、血府逐瘀汤、独活寄生汤及丹参、牛膝、延胡索是本研究常用中药。
- 使用中药时需关注与常规治疗的潜在相互作用,并个体化评估。
局限性
- 本研究为回顾性队列研究,非随机对照试验。
- 原文未报告中药具体剂量、疗程及不良反应数据。
- 原文未报告中药与常规治疗相互作用的直接证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Complications of type 2 diabetes (T2D) include stroke, which is a cerebrovascular disturbance characterized by reduced blood flow in the brain, leading to death or physical disability. Chinese herbal medicine (CHM) has been widely used in ancient China for the treatment of diabetes and stroke by supplementing Qi and activating blood circulation. AIM OF THE STUDY: This study aimed to investigate the frequencies and patterns of CHM treatment for stroke patients with T2D and the outcomes of long-term use in Taiwan. MATERIALS AND METHODS: We identified 3079 stroke patients (ICD-9-CM: 430-438) with T2D. We allocated 618 stroke patients, matched for age, gender, and T2D-to-stroke duration, to both CHM and non-CHM groups. Chi-square test, conditional multivariable logistic regression, Kaplan-Meier method, and the log-rank test were used in this study. RESULTS: The CHM group was characterized by more cases of chronic obstructive pulmonary disease, ulcer disease, hyperlipidemia, tobacco use, and higher income. The cumulative survival probability was higher in the CHM group (P<0.001, log rank test); after adjusting for comorbidities, income, and urbanization level, this group also exhibited a lower mortality hazard ratio (0.37, 95% confidence interval [0.25-0.55]). Shu-Jing-Huo-Xue-Tang, Xue-Fu-Zhu-Yu-Tang, and Du-Huo-Ji-Sheng-Tang; and Dan-Shen, Niu-Xi, and Yan-Hu-Suo represented the top three formulas and herbs, respectively. CONCLUSION: The use of CHM as adjunctive therapy may improve the overall survival (OS) of stroke patients with T2D. The list of the comprehensive herbal medicines that they used might be useful in future large-scale, randomized clinical investigations of agent effectiveness, safety, and potential interactions with conventional treatments in stroke patients with T2D.
引用
- Tsai FJ, Ho TJ, Cheng CF, et al. Effect of Chinese herbal medicine on stroke patients with type 2 diabetes. J Ethnopharmacol. 2017. PMID: 28213110. doi:10.1016/j.jep.2017.02.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。